Amryt Pharma’s mission is to improve the lives of patients suffering from rare and serious conditions

Amryt Pharma’s mission is to improve the lives of patients suffering from rare and serious conditions by developing and delivering high−quality,innovative therapies. The company’s vision is to be a global leader in the field of rare diseases, transforming the treatment landscape through cutting−edge science and compassionate care. Amryt Pharma focuses on several therapeutic areas, utilizing its expertise to develop treatments for conditions with high unmet medical needs: Amryt Pharma is advancing its treatment for EB, a rare genetic skin disorder that causes fragile skin prone to blistering. The company’s lead product, AP101, is a topical gel designed to address the symptoms of EB and improve patient quality of life.Another product in development for EB, Napalvobin, is aimed at providing a more effective treatment option for patients with this challenging condition.